Race White Black
No. % No. % P-value
Age P=0.008
<50 (n=52) 49 34% 3 27%
50 - 65 (n=84) 76 52% 8 73%
>65 (n=21) 21 14% 0 0%
Sex P = 0.997
Male (n=129) 120 82% 9 82%
Female (n=28) 26 18% 2 18%
Education P = 0.086
<High school (n=25) 22 15% 3 27%
High school graduate (n=41) 35 24% 6 55%
>high school (n=91) 89 61% 2 18%
Insurance (relative to private) Insurance (relative to private) P = 0.118
Private (n=93) 90 62% 3 27%
Medicaid/Medicare (n=24) 21 14% 3 27%
None (n=18) 15 10% 3 27%
Other (n=22) 20 14% 2 18%
Income P=0.001
>$50,000 (n=75) 75 53% 0 0%
$20,000 - $50,000 (n=49) 45 32% 4 36%
<$20,000 (n=29) 22 15% 7 64%
Rural/Urban Household P=0.536
Metropolitan (n=90) 85 81% 5 62%
Micropolitan (n=11) 10 10% 1 12%
Rural (n=12) 10 10% 2 25%
Driving Time to clinic biopsy (1st quartile (Q) as baseline) P=0.049
Q1 (n=20) 20 20% 0 0%
Q2 (n=31) 30 30% 1 14%
Q3 (n=27) 26 26% 1 14%
Q4 (n=30) 25 25% 5 71%
Smoking P=0.228
<10 Pack Years (n=66) 64 44% 2 18%
>10 Pack Years (n=90) 81 56% 9 82%
Alcohol use P=0.087
None (n=25) 24 17% 1 10%
Any (n=130) 121 83% 9 90%
T Stage P=0.173
T1 (n=43) 41 28% 2 18%
T2 (n=68) 66 45% 2 18%
T3 (n=24) 20 14% 4 36%
T4 (n=22) 19 13% 3 27%
Early (1-2) vs. Advanced T Stage (3-4) P=0.027
Early (n=111) 107 73% 4 36%
Advanced (n=46) 39 27% 7 64%
N stage P=0.857
N0 (n=29) 26 18% 3 27%
N1 (n=93) 88 60% 5 45%
N2 (n=20) 18 12% 2 18%
N3 (n=15) 14 10% 1 9%
M Stage P=0.889
M0 (n=155) 144 99% 11 100%
M1 (n=2) 2 1% 0 0%
Treatment Category P=0.805
Chemotherapy Only (n=1) 1 1% 0 0%
Radiation Only (n=11) 10 7% 1 9%
Surgery Only (n=7) 7 5% 0 0%
Concurrent chemoradiation (n=61) 54 37% 7 64%
Surgery + adjuvant radiation (n=36) 34 23% 2 18%
Surgery + adjuvant chemoradiation (n=41) 40 27% 1 9%
Number of Treatment Modalities P=0.472
1 (n=19) 18 12% 1 9%
2 (n=97) 88 60% 9 82%
3 (n=41) 40 27% 1 9%